Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

“Rehappy” health app delisted from the Directory of digital health applications in Germany

On September 26, 2022, the health app “Rehappy” was delisted from the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM).

This is the result of the evaluation of the BfArM, which concluded that the health app should be removed from the Directory in line with §139e 4 (8) of the SGB V as no evidence of the positive healthcare effect was identified.

The health app offered support for the aftercare of stroke patients. It was available in German with a reimbursement tariff of €299 (without a fitness tracker) and €449 (with a fitness tracker).

The full details in German can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.